LUCIUS 卢修斯 玛伐凯泰 Mavacamten阻塞性肥厚型 心肌病

玛伐凯泰

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Mavacamten

老挝国家食药监局批准上市
老挝国家药检所检测认证
阻塞性肥厚型

Compesition:

Each LuciMava carsule contains Mavacamten 2.5mg.

LUCIUS

Indicstion:

PHARMACEUTICALS

IuieiMava is a cardtac mvosta trimontor touicore
for the treatment of adulTs with SY mpIomkTe Nc

心肌病

Yark Heart Association (N)HA) Css II'Il
obstructive hvpcrtropmic cardiomyopathy (HC.M
to improve functional capacity and symptoms:
The recommendcd starting dose is ) me orally once

LuciMava

eu so 1ood, allowable subsequent
doscs wi watot are 22 ig. 3 me, 10me. or 15

daily Refer the full Prescribing information fo
sc 1s 13 ig orally once

Mavacamten Capsules

FDA批准

Capsules should be swallowed whole & not
chewed or crushed.

2.5 mg

Storage: in a dry place and store at 20°Cno 25C.

Warning:
Keen madicine
Keep medicine out of reach of Children. Do not
administer LuciMava during Pregnancy and
PLEASE SEE PACKAGE INSERT

Rx Only

Manufactured and Marketed by
LUCIUS

权威认证

Thongmang village, Xaythany district, Vientiane
Warning: To be sold by tetanl on presctiption
of registered phy

60
Capsules

口碑质量

适应症:
玛伐凯泰是一种心脏肌球蛋白抑制剂,用于治疗有症
状的纽约心脏协会(NYHA)II-III级阻塞性肥厚型心
肌病(HCM)的成年人,以改善功能能力和症状。
推荐剂量:
必须根据临床状况和超声心动图评估患者反应来确定
个体剂量。请参阅完整说明书。